One of the interesting applications for pediatric telemedicine is ophthalmology, where specialists are spread thin or don’t exist at all in many communities. Similar to teleradiology, non-physicians could be used to screen images to spot potential anomalies that need more urgent attention. A study by Dr. Graham E. Quinn, professor of ophthalmology at the Children’s […]
Around age 40, patients often develop a fuzziness of vision close up, presbyopia–becoming farsighted and losing elasticity in their natural lenses. Docs prescribe reading glasses or bifocals, and the eyes continue their decline. But Irvine, California-based startup LensGen hopes to mimic the lens’ natural movement with an implant. This intraocular lens would harness fluidics and displacement to manipulate curvature, […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A Children’s Hospital of Philadelphia spinout with the potential to be the first to win U.S. FDA approval of a gene therapy is now funded through the rest of development of its lead treatment for inherited blindness. Spark Therapeutics is in the middle of a Phase 3 clinical trial that will determine whether the gene therapy […]
Using thousands of baby photos, some off-the-shelf software and the help of his colleagues, an assistant professor of chemistry and biochemistry at Baylor University is on a personal mission to develop a better way to detect early signs of pediatric eye cancer.
Rather than using injections to deliver treatments to the middle and back of the eye, Kala Pharmaceuticals might have a way to get them there with topical drops. The Massachusetts-based company is developing eye drops designed to carry drugs through the layer of mucus on the eye’s surface — a barrier that typically gets in […]
A new ophthalmic drug company hoping to reformulate existing drugs to “bring better drugs, at better prices, to the patient” looks to be getting off the ground with some early capital. Eye-Pharma, founded by a retina surgeon and pharmaceutical executives from the company Ezra Innovations in 2013, disclosed in a new SEC filing that it’s […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Now that it’s gotten some sales traction and a fresh round of capital, Mobius Therapeutics is ready to double its sales force and ramp up education efforts for Mitosol, its first product for eye surgeons. What Mobius has done is take the drug mitomycin c, which ophthalmologists have been using for years off-label, and package […]
A one-year-old company using drug delivery to improve ophthalmic drugs is raising fresh capital to support trials of its microinjection platform. Clearside Biomedical has raised $7.9 million and could continue raising up to $8.5 million, according to a U.S. Securities and Exchange Commission filing made last week. The company is hoping to stave off retinal […]
With an aging population and rising rates of vision loss, the U.S. pharmaceutical and medical device industries have latched onto ophthalmology as an area where innovation is both needed and lucrative. Cleveland-area startup Visum Therapeutics is one of the companies going after an orphan eye disease called Stargardt disease, which is a juvenile manifestation of […]
For years ophthalmologists have been using the drug mitomycin C off-label to modulate wound healing during eye surgeries. In glaucoma filtering surgery, it’s known to prevent post-operative scarring and reduce the risk of surgical failure. But it’s tricky to work with, and until recently no one had taken on the work of getting it FDA […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
In the highly fragmented EMR market, how do you build an efficient product that doctors actually want to use? Maybe hire physicians in your target markets and join up with an entrepreneur who co-founded Blackboard, the popular virtual education company with more than 9,300 international clients and a $1.6 billion buyout? That was Modernizing Medicine’s […]
The fifth company spun out by the ophthalmology-focused incubator formed by Versant Ventures, Morgenthaler Ventures and Split Rock Partners has raised $8 million.
An aging population that has created a large pool of patients with eye diseases, changing demographics and an increased focus on combination therapies of drugs is boosting the global ophthalmology drugs and devices market now expected to grow to $52.4 billion by 2017. In 2010, MarketsandMarkets, which compiled the report, estimated the global ophthalmology drugs […]